Hemoglobin level predicts outcome for vulvar cancer patients independent of GLUT-1 and CA-IX expression in tumor tissue

Virchows Archiv

Volumn 457, Issue 6, 2010, Pages 693-703

  Van De Nieuwenhof, Hedwig P ^a   De Hullu, Joanne A ^a   Kaanders, Johannes H A M ^a   Bulten, Johan ^a   Massuger, Leon F A G ^a   Van Kempen, Léon C L T ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Anemia; Comorbidity; Hypoxia; Prognosis; Vulvar squamous cell carcinoma

Indexed keywords

CARBONATE DEHYDRATASE IX; GLUCOSE TRANSPORTER 1; HEMOGLOBIN;

ADULT; AGED; ANEMIA; ARTICLE; CANCER GRADING; CANCER INVASION; CANCER PATIENT; CANCER RECURRENCE; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; COMORBIDITY; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE FREE SURVIVAL; DISTANT METASTASIS; FEMALE; HEMOGLOBIN BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INGUINOFEMORAL METASTASIS; MAJOR CLINICAL STUDY; PREDICTION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; STAINING; TUMOR DIFFERENTIATION; VULVA CANCER; VULVAR SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; CARBONIC ANHYDRASES; CARCINOMA, SQUAMOUS CELL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUCOSE TRANSPORTER TYPE 1; HEMOGLOBINS; HUMANS; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL; VULVAR NEOPLASMS;

EID: 78651312486     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-010-0981-x     Document Type: Article

References (51)

1. Lataifeh I, Nascimento MC, Nicklin JL, Perrin LC, Crandon AJ, Obermair A (2004) Patterns of recurrence and disease-free survival in advanced squamous cell carcinoma of the vulva. Gynecol Oncol 95(3):701-705
2. Preti M, Ronco G, Ghiringhello B, Micheletti L (2000) Recurrent squamous cell carcinoma of the vulva: clinicopathologic determinants identifying low risk patients. Cancer 88(8):1869-1876
3. Raspagliesi F, Hanozet F, Ditto A, Solima E, Zanaboni F, Vecchione F et al (2006) Clinical and pathological prognostic factors in squamous cell carcinoma of the vulva. Gynecol Oncol 102(2):333-337
4. Oonk MH, Hollema H, de Hullu JA, van der Zee AG (2006) Prediction of lymph node metastases in vulvar cancer: a review. Int J Gynecol Cancer 16(3):963-971
5. van der Zee AG, Oonk MH, de Hullu JA, Ansink AC, Vergote I, Verheijen RH et al (2008) Sentinel node dissection is safe in the treatment of early-stage vulvar cancer. J Clin Oncol 26(6):884-889
6. Fons G, Burger MP, ten Kate FJ, van der Velden (2007) Identification of potential prognostic markers for vulvar cancer using immunohistochemical staining of tissue microarrays. Int J Gynecol Pathol 26(2):188-193
7. Growdon WB, Boisvert SL, Akhavanfard S, Oliva E, as-Santagata DC, Kojiro S et al (2008) Decreased survival in EGFR gene amplified vulvar carcinoma. Gynecol Oncol 111(2):289-297
8. Johnson GA, Mannel R, Khalifa M, Walker JL, Wren M, Min KW et al (1997) Epidermal growth factor receptor in vulvar malignancies and its relationship to metastasis and patient survival. Gynecol Oncol 65(3):425-429
9. Nayha VV, Stenback FG (2007) Increased angiogenesis is associated with poor prognosis of squamous cell carcinoma of the vulva. Acta Obstet Gynecol Scand 86(11):1392-1397
10. Obermair A, Kohlberger P, Bancher-Todesca D, Tempfer C, Sliutz G, Leodolter S et al (1996) Influence of microvessel density and vascular permeability factor/vascular endothelial growth factor expression on prognosis in vulvar cancer. Gynecol Oncol 63 (2):204-209
11. Oonk MH, de Bock GH, van der Veen T, Hoor KA, de Hullu JA, Hollema H et al (2007) EGFR expression is associated with groin node metastases in vulvar cancer, but does not improve their prediction. Gynecol Oncol 104(1):109-113
12. Varlotto J, Stevenson MA (2005) Anemia, tumour hypoxemia, and the cancer patient. Int J Radiat Oncol Biol Phys 63(1):25-36
13. Qutub AA, Popel AS (2007) Three autocrine feedback loops determine HIF1 alpha expression in chronic hypoxia. Biochim Biophys Acta 1773(10):1511-1525
14. Hoogsteen IJ, Marres HA, Bussink J, van der Kogel AJ, Kaanders JH (2007) Tumour microenvironment in head and neck squamous cell carcinomas: predictive value and clinical relevance of hypoxic markers. A review. Head Neck 29(6):591-604
15. Hockel M, Vorndran B, Schlenger K, Baussmann E, Knapstein PG (1993) Tumour oxygenation: a new predictive parameter in locally advanced cancer of the uterine cervix. Gynecol Oncol 51 (2):141-149
16. Kaanders JH, Wijffels KI, Marres HA, Ljungkvist AS, Pop LA, van den Hoogen FJ et al (2002) Pimonidazole binding and tumour vascularity predict for treatment outcome in head and neck cancer. Cancer Res 62(23):7066-7074
17. Sundfor K, Lyng H, Rofstad EK (1998) Tumour hypoxia and vascular density as predictors of metastasis in squamous cell carcinoma of the uterine cervix. Br J Cancer 78(6):822-827 (Pubitemid 28418321)
18. Gnarra JR, Zhou S, Merrill MJ, Wagner JR, Krumm A, Papavassiliou E et al (1996) Post-transcriptional regulation of vascular endothelial growth factor mRNA by the product of the VHL tumour suppressor gene. Proc Natl Acad Sci USA 93 (20):10589-10594
19. Hanahan D, Folkman J (1996) Patterns and emerging mechanisms of the angiogenic switch during tumourigenesis. Cell 86(3):353-364
20. Ivanov SV, Kuzmin I, Wei MH, Pack S, Geil L, Johnson BE et al (1998) Down-regulation of transmembrane carbonic anhydrases in renal cell carcinoma cell lines by wild-type von Hippel-Lindau\transgenes. Proc Natl Acad Sci USA 95(21):12596-12601
21. Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME et al (1999) The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399(6733):271-275
22. Macheda ML, Rogers S, Best JD (2005) Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer. J Cell Physiol 202(3):654-662
23. Sly WS, Hu PY (1995) Human carbonic anhydrases and carbonic anhydrase deficiencies. Annu Rev Biochem 64:375-401
24. Ivanov S, Liao SY, Ivanova A, Danilkovitch-Miagkova A, Tarasova N, Weirich G et al (2001) Expression of hypoxiainducible cell-surface transmembrane carbonic anhydrases in human cancer. Am J Pathol 158(3):905-919
25. Vaupel P, Mayer A (2005) Hypoxia and anemia: effects on tumour biology and treatment resistance. Transfus Clin Biol 12(1):5-10
26. Hoogsteen IJ, Marres HA, van der Kogel AJ, Kaanders JH (2007) The hypoxic tumour microenvironment, patient selection and hypoxia-modifying treatments. Clin Oncol (R Coll Radiol) 19 (6):385-396
27. Kelleher DK, Mattheinsen U, Thews O, Vaupel P (1996) Blood flow, oxygenation, and bioenergetic status of tumours after erythropoietin treatment in normal and anemic rats. Cancer Res 56(20):4728-4734
28. Airley R, Loncaster J, Davidson S, Bromley M, Roberts S, Patterson A et al (2001) Glucose transporter glut-1 expression correlates with tumour hypoxia and predicts metastasis-free survival in advanced carcinoma of the cervix. Clin Cancer Res 7 (4):928-934
29. Cantuaria G, Fagotti A, Ferrandina G, Magalhaes A, Nadji M, Angioli R et al (2001) GLUT-1 expression in ovarian carcinoma: association with survival and response to chemotherapy. Cancer 92(5):1144-1150
30. Chia SK, Wykoff CC, Watson PH, Han C, Leek RD, Pastorek J et al (2001) Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma. J Clin Oncol 19(16):3660-3668
31. Fortin A, Wang CS, Vigneault E (2008) Effect of pretreatment anemia on treatment outcome of concurrent radiochemotherapy in patients with head and neck cancer. Int J Radiat Oncol Biol Phys 72(1):255-260
32. Furudoi A, Tanaka S, Haruma K, Yoshihara M, Sumii K, Kajiyama G et al (2001) Clinical significance of human erythrocyte glucose transporter 1 expression at the deepest invasive site of advanced colorectal carcinoma. Oncology 60 (2):162-169
33. Giatromanolaki A, Koukourakis MI, Sivridis E, Turley H, Talks K, Pezzella F et al (2001) Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival. Br J Cancer 85(6):881-890
34. Koukourakis MI, Giatromanolaki A, Sivridis E, Simopoulos K, Pastorek J, Wykoff CC et al (2001) Hypoxia-regulated carbonic anhydrase-9 (CA9) relates to poor vascularization and resistance of squamous cell head and neck cancer to chemoradiotherapy. Clin Cancer Res 7(11):3399-3403
35. Loncaster JA, Harris AL, Davidson SE, Logue JP, Hunter RD, Wycoff CC et al (2001) Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: correlations with tumour oxygen measurements and prognosis in locally advanced carcinoma of the cervix. Cancer Res 61(17):6394-6399
36. Winter WE III, Maxwell GL, Tian C, Sobel E, Rose GS, Thomas G et al (2004) Association of hemoglobin level with survival in cervical carcinoma patients treated with concurrent cisplatin and radiotherapy: a Gynecologic Oncology Group Study. Gynecol Oncol 94(2):495-501
37. Stone JE, Parker R, Gilks CB, Stanbridge EJ, Liao SY, Quino-Parsons C (2005) Intratumoural oxygenation of invasive squamous cell carcinoma of the vulva is not correlated with regional lymph node metastasis. Eur J Gynaecol Oncol 26(1):31-35
38. Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40 (5):373-383
39. Koukourakis MI, Giatromanolaki A, Sivridis E, Pastorek J, Karapantzos I, Gatter KC et al (2004) Hypoxia-activated tumour pathways of angiogenesis and pH regulation independent of anemia in head-and-neck cancer. Int J Radiat Oncol Biol Phys 59(1):67-71
40. Koukourakis MI, Giatromanolaki A, Polychronidis A, Simopoulos C, Gatter KC, Harris AL et al (2006) Endogenous markers of hypoxia/anaerobic metabolism and anemia in primary colorectal cancer. Cancer Sci 97(7):582-588
41. Caro JJ, Salas M, Ward A, Goss G (2001) Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review. Cancer 91(12):2214-2221
42. Wu WC, Schifftner TL, Henderson WG, Eaton CB, Poses RM, Uttley G et al (2007) Preoperative hematocrit levels and postoperative outcomes in older patients undergoing noncardiac surgery. JAMA 297(22):2481-2488
43. Dunst J, Kuhnt T, Strauss HG, Krause U, Pelz T, Koelbl H et al (2003) Anemia in cervical cancers: impact on survival, patterns of relapse, and association with hypoxia and angiogenesis. Int J Radiat Oncol Biol Phys 56(3):778-787
44. Jonathan RA, Wijffels KI, Peeters W, de Wilde PC, Marres HA, Merkx MA et al (2006) The prognostic value of endogenous hypoxia-related markers for head and neck squamous cell carcinomas treated with ARCON. Radiother Oncol 79(3):288-297
45. Mayer A, Hockel M, Wree A, Vaupel P (2005) Microregional expression of glucose transporter-1 and oxygenation status: lack of correlation in locally advanced cervical cancers. Clin Cancer Res 11(7):2768-2773 (Pubitemid 40569479)
46. Stewart GD, Gray K, Pennington CJ, Edwards DR, Riddick AC, Ross JA et al (2008) Analysis of hypoxia-associated gene expression in prostate cancer: lysyl oxidase and glucose transporter-1 expression correlate with Gleason score. Oncol Rep 20(6):1561-1567
47. Lal A, Peters H, St CB, Haroon ZA, Dewhirst MW, Strausberg RL et al (2001) Transcriptional response to hypoxia in human tumours. J Natl Cancer Inst 93(17):1337-1343
48. Wykoff CC, Beasley NJ, Watson PH, Turner KJ, Pastorek J, Sibtain A et al (2000) Hypoxia-inducible expression of tumourassociated carbonic anhydrases. Cancer Res 60(24):7075-7083
49. Bui MH, Seligson D, Han KR, Pantuck AJ, Dorey FJ, Huang Yet al (2003) Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy. Clin Cancer Res 9(2):802-811
50. Murakami Y, Kanda K, Tsuji M, Kanayama H, Kagawa S (1999) MN/CA9 gene expression as a potential biomarker in renal cell carcinoma. BJU Int 83(7):743-747
51. Rasheed S, Harris AL, Tekkis PP, Turley H, Silver A, McDonald PJ et al (2009) Assessment of microvessel density and carbonic anhydrase-9 (CA-9) expression in rectal cancer. Pathol Res Pract 205(1):1-9